International conference on basic and clinical aspects of cell-cycle control

Journal of Cellular Physiology

Volumn 185, Issue 3, 2000, Pages 481-485

  Stiegler, Peter ^a   Giordano, Antonio ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CELL CYCLE; CELL DEATH; CELL SURVIVAL; CONFERENCE PAPER; DNA DAMAGE; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DEATH; DNA DAMAGE; HUMANS; NEOPLASMS;

ANIMALIA;

EID: 0033773193     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4652(200012)185:3<481::AID-JCP20>3.0.CO;2-O     Document Type: Conference Paper

References (35)

1. Persistence of p53 mutations and resistance of keratinocytes to apoptosis are associated with the increased susceptibility of mice lacking the XPC gene to UV carcinogenesis
2. Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors
3. Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes
4. The RB2/p130 gene: The latest weapon in the war against lung cancer?
5. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer
6. Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas
7. Disruption of the ARF-Mdm2-53 tumor suppressor pathway in Myc-induced lymphomagenesis
8. Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease
9. Creation of human tumour cells with defined genetic elements
10. The hallmarks of cancer
11. Processing of cyclin E differs between normal and tumor breast cells
12. Inducible pRb2/p130 expression and growth-suppressive mechanisms: Evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop
13. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function
14. Synthesis and evaluation of geldanamycin-estradiol hybrids
15. Predicting cancer development in oral leukoplakia: Ten years of translational research
16. Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: Distinct mechanisms of cell growth control
17. Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: A multivariate cluster analysis
18. Rapid destruction of human Cdc25A in response to DNA damage
19. Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy
20. Jeremiah Metzger Lecture. Targeted cancer therapy
21. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion
22. Cellular and molecular mechanisms of asbestos-induced fibrosis
23. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer
24. p53 Tumor suppressor gene therapy for cancer
25. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway
26. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
27. Deregulated cyclin E induces chromosome instability
28. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells
29. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
30. Developmental defects and tumor predisposition in Rb mutant mice
31. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse
32. Disorders in cell circuitry during multistage carcinogenesis: The role of homeostasis
33. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts
34. Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases
35. Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion